DIALYSIS STATUS IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN KOREA- BASED ON 12-YEARS NATIONAL SAMPEL COHORT DATABASE
Author(s)
Jung S1, Ha J2, Jang EJ3, Sohn HS4
1Sookmyung Women's University, Seoul, Korea, Republic of (South), 2CHA university, Seongnam-si, Korea, Republic of (South), 3Andong National University, Andong-si, Korea, Republic of (South), 4CHA University, Seongnam-si, Korea, Republic of (South)
OBJECTIVES: To determine overall dialysis status, healthcare utilization, and subject demographics, clinical and financial aspect of chronic kidney disease(CKD) patients with either peritoneal dialysis (PD) or hemodialysis (HD) in Korea. METHODS: In this retrospective, observational study, we used the Korean National Health Insurance Service-Sample Cohort Database from 2002 to 2013 (n=1,025,340). Subjects with PD or HD due to CKD (International Classification of Diseases 10th Revision code N18 or N19) were enrolled in this study. Data analysis was performed by using SAS, version 9.4. SAS. RESULTS: Total number of patients with dialysis was 1,481(HD 1,311 and PD 170) in 2013. HD was the main dialysis modality(89%) rather than PD. Expected number of dialysis patients which was standardized by year 2013 population, were 143.8 and 18.6 patients per 100,000 persons for HD and PD, respectively, in 2013. These numbers were about 4-fold and 2.5-fold increases comparing to 2002. However, Percentages of patients aged less than 60 years was higher in PD than HD (67% vs. 44%), and employee subscribers for national health insurance was higher in PD than HD (55% vs. 47%). Patients of medical aid not national health insurance subscribers were highest in patients on dialysis (22%) among all patients with CKD. Annual total medical costs (median) per dialysis patient were US$23,390 for HD and US$18,945 PD in 2013(US1=KRW1,100). PD were treated mainly in tertiary hospitals (98%), whereas HD were both in primary clinics(51%) and tertiary hospitals(37%). Comorbid hypertension and diabetes in dialysis patients were 73% and 48%, respectively. CONCLUSIONS: Rapid increase of dialysis in CKD patients in recent years and higher prevalence of HD shown in this study assumed to significantly impact on the national health insurance budget continuously in the aging era. Therefore, appropriate strategies to efficiently reduce clinical and financial risks from dialysis treatment in CKD patients.
Conference/Value in Health Info
2017-11, ISPOR Europe 2017, Glasgow, Scotland
Value in Health, Vol. 20, No. 9 (October 2017)
Code
PHS109
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Urinary/Kidney Disorders